Sanofi, Regeneron Begin Kevzara Clinical Trial For Severe COVID-19

PARIS (dpa-AFX) – Sanofi (SNY, SNYNF) and Regeneron Pharmaceuticals, Inc. (REGN) announced Monday they have started a clinical program evaluating Kevzara (sarilumab) in patients hospitalized with …
FinanzNachrichten.de: Meistgelesene Nachrichten

Tags: BeginclinicalCOVID19KevzaraNachrichtenPharmaceuticalsRegeneronSanofiSevereTrialwith